The Advisory Group:

Advise — Provide advisory support and strategic guidance on topics aligned with the mission, vision and priorities of the Enterprise.

Endorse — Provide feedback on and endorse the Enterprise’s strategic plan, goals and initiatives.

Inform — Share technical expertise on HIV vaccine-related inquiries from the Enterprise team.

Review — Maintain awareness of the Enterprise’s progress against performance goals through review of regular reporting by the Enterprise team.

Connect — Suggest and (where appropriate) introduce potential partners and collaborators that can help fund, plan and support Enterprise activities and fill knowledge gaps.

Guiding principles

The following principles will underpin the activities of the Enterprise Advisory Group:

Support the achievement of endorsed Enterprise strategic plan, goals and initiatives.

Serve as objective advisers to the Enterprise.

Act in a responsive, transparent and collaborative manner with EAG members, the Enterprise team and the IAS Governing Council.

Represent the views, interests and priorities of IAS members and partner organizations and of the HIV vaccine community.

Governance

The EAG is advisory to the Enterprise hosted at IAS, and is independent of the IAS Governing Council. As a strictly advisory, non-governing body, the EAG does not have either decision-making authority or fiduciary responsibilities. A quorum will not be required.

Members/Composition

The EAG is composed of highly committed individuals with capacity to provide strategic and technical advice on HIV vaccines. Other experts may be invited to the meetings if the need arises. The EAG is formed with a commitment to both gender and regional balance, and includes at least one community representative.